These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31060247)

  • 21. Drug compatibility in neonatal intensive care units: gaps in knowledge and discordances.
    Fernández-Peña A; Katsumiti A; De Basagoiti A; Castaño M; Ros G; Sautua S; De Miguel M; Campino A
    Eur J Pediatr; 2021 Jul; 180(7):2305-2313. PubMed ID: 33738517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings.
    Senarathna SMDKG; Strunk T; Petrovski M; Woodland S; Martinez J; Chuang VTG; Batty KT
    Eur J Hosp Pharm; 2023 Oct; ():. PubMed ID: 37875283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Nov; 50(11):2359-63. PubMed ID: 8266963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compatibility of commonly used bone marrow transplant drugs during Y-site delivery.
    Najari Z; Rusho WJ
    Am J Health Syst Pharm; 1997 Jan; 54(2):181-4. PubMed ID: 9117807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical compatibility of milrinone lactate injection with intravenous drugs commonly used in the pediatric intensive care unit.
    Veltri MA; Conner KG
    Am J Health Syst Pharm; 2002 Mar; 59(5):452-4. PubMed ID: 11887412
    [No Abstract]   [Full Text] [Related]  

  • 26. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
    De Silva DTN; Petrovski M; Strunk T; Mukadam N; Page-Sharp M; Moore BR; Batty KT
    Eur J Clin Pharmacol; 2024 Jul; 80(7):1079-1087. PubMed ID: 38546840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
    Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
    Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical compatibility of pentoxifylline and intravenous medications.
    Senarathna SMDKG; Strunk T; Petrovski M; Batty KT
    Arch Dis Child; 2019 Mar; 104(3):292-295. PubMed ID: 30472662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
    Holt RJ; Siegert SW; Krishna A
    J Pediatr Pharmacol Ther; 2008 Jul; 13(3):156-61. PubMed ID: 23055876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.
    Kidd JM; Avery LM; Asempa TE; Nicolau DP; Kuti JL
    Clin Ther; 2018 Feb; 40(2):261-269. PubMed ID: 29290374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.
    Staven V; Wang S; Grønlie I; Tho I
    Nutr J; 2016 Mar; 15():29. PubMed ID: 27000057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Y-site simulation compatibility study of 10% calcium salts with various injectable solutions during toxicological resuscitation.
    Hamelin A; Thompson-Desormeaux F; Elliott A; Friciu M; Forest JM; Leclair G
    Eur J Hosp Pharm; 2023 Jul; ():. PubMed ID: 37438091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery.
    Condie CK; Tyler LS; Barker B; Canann DM
    Am J Health Syst Pharm; 2008 Mar; 65(5):454-7. PubMed ID: 18281738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit.
    Gikic M; Di Paolo ER; Pannatier A; Cotting J
    Pharm World Sci; 2000 Jun; 22(3):88-91. PubMed ID: 11028261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
    Kufel WD; Miller CD; Johnson PR; Reid K; Zahra JJ; Seabury RW
    Hosp Pharm; 2017 Feb; 52(2):132-137. PubMed ID: 28321140
    [No Abstract]   [Full Text] [Related]  

  • 37. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physical compatibility of furosemide in intravenous mixtures for continuous perfusion].
    Pérez Juan E; Maqueda Palau M; Arévalo Rubert M; Ribas Nicolau B; Amorós Cerdá SM
    Enferm Intensiva; 2010; 21(3):96-103. PubMed ID: 20413337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration.
    Foushee JA; Fox LM; Gormley LR; Lineberger MS
    Am J Health Syst Pharm; 2015 Mar; 72(6):483-6. PubMed ID: 25736944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a compatibility chart for intravenous Y-site drug administration in a pediatric intensive care unit.
    Manrique-Rodríguez S; Sánchez-Galindo A; Mora-García T; Fernandez-Llamazares CM; Echarri-Martínez L; López-Herce J; Rodríguez-Gómez M; Bellón-Cano JM; Sanjuro-Sáez M
    J Infus Nurs; 2012; 35(2):109-14. PubMed ID: 22382795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.